(Q58870900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Stephen Wood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Katherine Kasha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Denis Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Stéphane Rioux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bernard Brodeur

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

H Dele Davies

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

27 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

47-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

6905-6912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

The prevention of early-onset group B streptococcal infections in the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

7 January 2021

Group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Group B streptococcal conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Combination conjugate vaccines against multiple serotypes of group B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Quantitation of serum antibodies to surface antigens of group B streptococci types Ia, Ib, and III: low antibody levels in mothers of neonatally infected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Mothers of infants with neonatal group B streptococcal septicemia are poor responders to bacterial carbohydrate antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Identification of a universal Group B streptococcus vaccine by multiple genome screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Antibodies to Capsular Polysaccharides of Group BStreptococcusin Pregnant Canadian Women: Relationship to Colonization Status and Infection in the Neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Placental transport of immunoglobulin G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Relation between maternal age and serum concentration of IgG antibody to type III group B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Identification of a family of streptococcal surface proteins with extremely repetitive structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

7 January 2021

inferred from DOI database lookup

Group B streptococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

7 January 2021

inferred from DOI database lookup

The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.020

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2006.06.020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844270%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference